OpGen, Inc. (OPGN) Reaches $2.12 After 4.00% Down Move; Spx (SPXC) Shorts Up By 23.98%

June 14, 2018 - By Hazel Jackson

SPX Corporation (NYSE:SPXC) Logo

The stock of OpGen, Inc. (NASDAQ:OPGN) is a huge mover today! The stock decreased 8.04% or $0.185 during the last trading session, reaching $2.115. About 322,169 shares traded. OpGen, Inc. (NASDAQ:OPGN) has declined 88.48% since June 14, 2017 and is downtrending. It has underperformed by 101.05% the S&P500.The move comes after 5 months negative chart setup for the $12.61 million company. It was reported on Jun, 14 by Barchart.com. We have $2.03 PT which if reached, will make NASDAQ:OPGN worth $504,480 less.

Spx Corporation (NYSE:SPXC) had an increase of 23.98% in short interest. SPXC’s SI was 637,900 shares in June as released by FINRA. Its up 23.98% from 514,500 shares previously. With 284,900 avg volume, 2 days are for Spx Corporation (NYSE:SPXC)’s short sellers to cover SPXC’s short positions. The SI to Spx Corporation’s float is 1.54%. The stock decreased 0.16% or $0.06 during the last trading session, reaching $37.5. About 84,287 shares traded. SPX Corporation (NYSE:SPXC) has risen 35.09% since June 14, 2017 and is uptrending. It has outperformed by 22.52% the S&P500. Some Historical SPXC News: ; 03/05/2018 – SPX CORP 1Q REV. $351.9M; 23/04/2018 – SPX Unit Will Be Merged With CUES’ Parent Company, Elxsi Corp; 16/05/2018 – SPX – A Dual TF (Time Frame) Look; 03/05/2018 – SPX CORP – REAFFIRMING 2018 GUIDANCE; 03/05/2018 – SPX Corp Sees 2018 Adj EPS $2.03-Adj EPS $2.18; 05/04/2018 – Copper Rock Capital Partners Buys New 1.4% Position in SPX Corp; 23/04/2018 – CBOE Rules: Notice of Filing and Immediate Effectiveness of a Proposed Rule Change in Connection with the Migration of SPX; 26/03/2018 – Moody’s affirmed SPX FLOW CFR at Ba3; outlook changed to stable from negative; 03/05/2018 – SPX CORP SPXC.N SEES FY 2018 ADJUSTED SHR $2.03 TO $2.18; 03/05/2018 – SPX Corp 1Q EPS 28c

More recent OpGen, Inc. (NASDAQ:OPGN) news were published by: Globenewswire.com which released: “OpGen Modifies Terms of Debt with Merck Global Health Innovation Fund” on June 14, 2018. Also Nasdaq.com published the news titled: “OpGen Presents Data at ASM Microbe 2018 Demonstrating High Accuracy of Acuitas® for Predicting Antibiotic …” on June 12, 2018. Benzinga.com‘s news article titled: “42 Biggest Movers From Yesterday” with publication date: June 13, 2018 was also an interesting one.

Among 2 analysts covering OpGen (NASDAQ:OPGN), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. OpGen had 11 analyst reports since June 29, 2016 according to SRatingsIntel. As per Thursday, April 5, the company rating was maintained by H.C. Wainwright. The firm earned “Buy” rating on Friday, March 16 by H.C. Wainwright. The firm has “Buy” rating given on Tuesday, July 18 by H.C. Wainwright. On Friday, April 20 the stock rating was maintained by H.C. Wainwright with “Buy”. The stock of OpGen, Inc. (NASDAQ:OPGN) earned “Buy” rating by H.C. Wainwright on Wednesday, August 9. Rodman & Renshaw initiated it with “Buy” rating and $2.50 target in Wednesday, June 29 report. The rating was maintained by H.C. Wainwright on Wednesday, May 9 with “Buy”. The firm earned “Buy” rating on Tuesday, October 24 by H.C. Wainwright. The stock of OpGen, Inc. (NASDAQ:OPGN) earned “Buy” rating by H.C. Wainwright on Wednesday, February 7. H.C. Wainwright maintained the shares of OPGN in report on Wednesday, November 8 with “Buy” rating.

OpGen, Inc., a precision medicine company, engages in developing molecular information services and products to combat infectious diseases in the healthcare industry worldwide. The company has market cap of $12.61 million. The firm utilizes molecular diagnostics and bioinformatics to help combat infectious diseases. It currently has negative earnings. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms.

Analysts await OpGen, Inc. (NASDAQ:OPGN) to report earnings on August, 14. They expect $-0.60 EPS, up 84.00% or $3.15 from last year’s $-3.75 per share. After $-0.75 actual EPS reported by OpGen, Inc. for the previous quarter, Wall Street now forecasts -20.00% EPS growth.

SPX Corporation supplies infrastructure equipment serving the heating and ventilation , detection and measurement, power transmission and generation, and industrial markets in the United States, China, South Africa, the United Kingdom, and internationally. The company has market cap of $1.61 billion. It operates through three divisions: HVAC, Detection and Measurement, and Engineered Solutions. It has a 19.69 P/E ratio. The HVAC segment engineers, designs, makes, installs, and services cooling products for the HVAC and industrial markets, as well as boilers, comfort heating, and ventilation products for the residential and commercial markets.

More news for SPX Corporation (NYSE:SPXC) were recently published by: Globenewswire.com, which released: “SPX Completes Acquisition of CUES, Inc.” on June 07, 2018. Globenewswire.com‘s article titled: “Report: Exploring Fundamental Drivers Behind Titan Machinery, Kforce, Liberty Media, Daktronics, SPX, and Tallgrass …” and published on May 29, 2018 is yet another important article.

SPX Corporation (NYSE:SPXC) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Hazel Jackson

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts